(Circulation. 2000;101:86.)
© 2000 American Heart Association, Inc.
Basic Science Reports |
From Anesthésiologie Expérimentale et Physiologie Cellulaire, Université, Caen (R.R., S.P., J.-L.G.); Pharmacologie, Centre dInvestigations Cliniques, CH&U-INSERM, Hôpital Cardiologique, Lille (C.L.), France; and Pfizer Ltd, Central Research, Sandwich, Kent CT13 9NJ, UK (M.G., C.A.).
Correspondence to Sandra Picard, Anesthésiologie Expérimentale et Physiologie Cellulaire, Université, Campus I, Esplanade de la Paix, 14032 Caen Cedex, France.
BackgroundTo evaluate both class III activity and antiarrhythmic action of dofetilide at the level of the "border zone," we investigated its electrophysiological effects on guinea pig ventricular strips submitted partly to normoxia (normal zone, NZ) and partly to simulated severe ischemia, then reperfusion (altered zone, AZ).
Methods and ResultsBecause of the differential class III effects of dofetilide in normal and ischemic regions, the dispersion of the action potential duration at 90% repolarization (APD90) between NZ and AZ was reduced by 5 nmol/L of drug during early ischemia (at 10 minutes, APD90 NZ/APD90 AZ was 1.68±0.22 versus 2.82±0.17 in control, P<0.05), whereas 50 nmol/L dofetilide worsened it during late ischemia (at 30 minutes, APD90 NZ/APD90 AZ was 4.62±0.76 versus 2.57±0.21 in control, P<0.05). Concomitantly, dofetilide at 5, 10, and 50 nmol/L abolished the early extrastimulus (ES)-induced arrhythmias, and at 10 and 50 nmol/L, it significantly enhanced the incidence of late spontaneous repetitive responses (in 86% and 75% of preparations treated with 10 and 50 nmol/L, respectively, versus 25% in control, P<0.05). During reperfusion, dofetilide at 5, 10, and 50 nmol/L exhibited concentration-dependent class III effects, as it did in the NZ, and did not modify the incidence of spontaneous arrhythmias.
ConclusionsDofetilide 5 nmol/L decreased APD90 dispersion between NZ and AZ and reduced the early ES-induced arrhythmias. However, dofetilide 50 nmol/L increased APD90 dispersion, and at 10 and 50 nmol/L, it increased the late spontaneous arrhythmias.
Key Words: antiarrhythmia agents ischemia reperfusion myocardium
This article has been cited by other articles:
![]() |
J.-L. Hanouz, Y. Repesse, L. Zhu, S. Lemoine, R. Rouet, L. Salle, B. Plaud, and J.-L. Gerard The Electrophysiological Effects of Racemic Ketamine and Etomidate in an In Vitro Model of "Border Zone" Between Normal and Ischemic/Reperfused Guinea Pig Myocardium Anesth. Analg., February 1, 2008; 106(2): 365 - 370. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-L. Hanouz, A. Yvon, F. Flais, R. Rouet, P. Ducouret, H. Bricard, and J.-L. Gerard Propofol Decreases Reperfusion-Induced Arrhythmias in a Model of "Border Zone" Between Normal and Ischemic-Reperfused Guinea Pig Myocardium Anesth. Analg., November 1, 2003; 97(5): 1230 - 1238. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Yvon, J.-L. Hanouz, X. Terrien, P. Ducouret, R. Rouet, H. Bricard, and J.-L. Gerard Electrophysiological effects of morphine in an in vitro model of the 'border zone' between normal and ischaemic-reperfused guinea-pig myocardium Br. J. Anaesth., December 1, 2002; 89(6): 888 - 895. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |